Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.
Mohamed L
ML
Sorror
Wendy
W
Leisenring
H Joachim
HJ
Deeg
Paul J
PJ
Martin
Rainer
R
Storb
D000741:Anemia, Aplastic / Q000628:therapy*; D016026:Bone Marrow Transplantation; D016572:Cyclosporine / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006086:Graft vs Host Disease / Q000150:complications / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D008727:Methotrexate